Home
Applications
Indications
Business
EpiSwitch
®
Products
EpiSwitch® COVID-19 Severity Test
EpiSwitch
®
Explorer Array Kit
EpiSwitch
®
Service
Investors
Investors Overview
Results and Presentations
Share Price Information
Regulatory News
Board & Governance
Key Corporate Documents
AIM Rule 26
Email Alerts
Investor Contacts
News
About Us
History
Board of Directors
Management Team
Scientific Advisory Panel
Values
Careers
Contact Us
Oxford Biodynamics Plc enters into master service agreement with world leading US pharmaceutical company to evaluate EpiSwitch™ biomarkers
December 20, 2019
|
In
Milestones
|
By
oxfordbiodynamics
Press Release
Prev
Next
Privacy Preference Center
Privacy Preferences
